| Title |
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
|
|---|---|
| Published in |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, September 2011
|
| DOI | 10.2147/dmso.s20633 |
| Pubmed ID | |
| Authors |
Nitil Kedia |
| Abstract |
Tight glycemic control is important in reducing and delaying vascular complications in type 1 and 2 diabetes patients; however, the benefits achieved through strict metabolic control are counterbalanced by an increased risk of hypoglycemia. Glucagon is an effective therapy for treating severe hypoglycemia. Available as an emergency kit, glucagon is an essential tool for rapid response, but remains underappreciated and underused. This article reviews the role of glucagon in treating severe hypoglycemia and discusses the need for better education on glucagon for people with diabetes and their caregivers in order to alleviate fears of hypoglycemia and of administering glucagon in the event of an emergency. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | <1% |
| United Kingdom | 1 | <1% |
| India | 1 | <1% |
| Chile | 1 | <1% |
| Unknown | 200 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 43 | 21% |
| Student > Master | 20 | 10% |
| Student > Ph. D. Student | 19 | 9% |
| Researcher | 15 | 7% |
| Student > Postgraduate | 14 | 7% |
| Other | 30 | 15% |
| Unknown | 64 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 24% |
| Nursing and Health Professions | 29 | 14% |
| Agricultural and Biological Sciences | 16 | 8% |
| Biochemistry, Genetics and Molecular Biology | 10 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 5% |
| Other | 25 | 12% |
| Unknown | 65 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2023.
All research outputs
#2,291,320
of 25,728,855 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#115
of 1,190 outputs
Outputs of similar age
#11,050
of 136,882 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#1
of 4 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,190 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 136,882 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them